The effects of atypical antipsychotics on woman's fertility and pregnancy: Case report;Atipik antipsikotiklerin kadin fertilitesi ve gebelik üzerine etkileri: Olgu sunumu

Klinik Psikofarmakoloji Bulteni

Volumn 15, Issue 4, 2005, Pages 182-186

  Altintoprak, A Ender ^a   Erol, Ayşe ^a   Koturoǧlu, Güldane ^a   Gönül, Ali Saffet ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Atypical antipsychotics; Olanzapine; Pregnancy; Teratogenity

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; OLANZAPINE;

ADULT; ARTICLE; CASE REPORT; EXTRAPYRAMIDAL SYNDROME; FEMALE; FEMALE FERTILITY; HUMAN; HYPERPROLACTINEMIA; INFANTICIDE; MENTAL DISEASE; PREGNANCY; PRENATAL DRUG EXPOSURE; PSYCHOSIS; SEXUAL DYSFUNCTION; SUICIDE ATTEMPT;

EID: 31644449207     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hollister LE. Treatment of pshchiatric disorders. In Clinical Pharmacology, Basic Principles in Therapeutics, Carruthers SG, Hoffman BB, Melmon KL, Nierenberg DW (editors). 4th ed., New York: McGraw-Hill 2000: 489-528
2. Markowitz JS, Brown CS, Moore TR. Atypical antipsychotics. Part I: pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother 1999; 33: 73-85
3. Guille C, Sachs GS, Ghaemi SN. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2000; 61: 638-642
4. Conley RR, Mahmoud R. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Am J Psychiatry 2001; 158: 765-774
5. Narendran R, Young CM, Valenti AM, Pristach CA, Pato MT, Grace JJ. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. J Clin Psychiatry 2001; 62: 509-516
6. Altshuler LL, Szuba MP. Course of psychiatric disorders in pregnancy: dilemmas in pharmacologic management. Neurol Clin 1994; 12: 613-635
7. Kayaalp SO. Nöroleptik ilaçlar. Rasyonel Tedavi Yönünden Tibbi Farmakoloji. 10. Baski, Ankara: Hacettepe Taş, 2002: 934-954
8. Goldberg HL. Psychotropic drugs in pregnancy and lactation. Int J Psychiatry Med 1994; 24: 129-149
9. Sophocles AM, Brozovich EM. Birth control failure among patients with unwanted pregnancies. J Fam Pract 1986; 22: 45-48
10. Miller LJ. Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull 1997; 23 :623-635
11. Craig M, Abel K. Prescribing for psychiatric disorders in pregnancy and lactation. Best Pract Res Clin Obstet Gynaecol 2001; 15: 1013-1030
12. Sweetman SC, Blake PS, McGlashan JM, Parsons AV (editors). Anxiolytic Sedatives Hypnotics and Antipsychotics. In Martindale: The Extra Pharmacopoeia. 33th ed., London: Pharmaceutical Press, 2002: 649-714
13. Goodnick PJ, Rodriguez L, Santana O. Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother 2002; 3: 1381-1391
14. Stahl MS. Antipsychotic agents. In Essential psychopharmacology. 2nd ed., Cambridge: Cambridge University Press, 2000: 401-458
15. Meaney AM, O'Keane V. Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia. Life Sci 2002; 71: 979-992
16. Crawford AM, Beasley CM Jr, Tollefson GD. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. Schizophr Res 1997; 26: 41-54
17. Tolis G, Friesen HG. Prolactin and human reproduction. Can Med Assoc J 1976; 115: 709-711
18. Jones B, Basson BR, Walker DJ, Crawford AM, Kinon BJ. Weight change and atypical antipsychotic treatment in patients with schizophrenia. J Clin Psychiatry 2001; 62 (suppl 2): S41-S44
19. Lindenmayer JP, Nathan AM, Smith RC. Hyperglycemia associated with the use of atypical antipsychotics. J Clin Psychiatry 2001; 62 (suppl 23): 30-38
20. Koren G. Maternal obesity and risk of neural tube defects. Can Fam Physician. 2001; 47: 1385-1387
21. Gill TS, Guram MS, Geber WF. Haloperidol teratogenicity in the fetal hamster. Dev Pharmacol Ther 1982; 4: 1-5
22. Jurand A, Martin LV. Teratogenic potential of two neurotropic drugs, haloperidol and dextromoramide, tested on mouse embryos. Teratology 1990; 42: 45-54
23. Abdel-Hamid HA, Abdel-Rahman MS, Abdel-Rahman SA. Teratogenic effect of diphenylhydantoin and/or fluphenazine in mice. J Appl Toxicol 1996; 16: 221-225
24. Druga A, Nyitray M, Szaszovszky E. Experimental teratogenicity of structurally similar compounds with or without piperazine-ring: a preliminary report. Pol J Pharmacol Pharm 1980; 32: 199-204
25. Sophocles AM, Brozovich EM. Birth control failure among patients with unwanted pregnancies. J Fam Pract 1986;22:45-48
26. Miller LJ. Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull 1997;23:623-635
27. Goldberg HL. 1994. Psychotropic drugs in pregnancy and lactation. Int J Psychiatry Med. 24:129-147
28. Briggs GG, Freeman RK, Yaffe SJ (editors). Haloperidol. In Drugs in pregnancy and lactation. 5th ed., Philadelphia: Lippincot-Williams & Wilkins, 1998: 498
29. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother. 2004; 38: 1265-1271
30. Dickson RA, Dawson DT. Olanzapine and pregnancy [letter]. Can J Psychiatry 1998; 43: 196-197
31. Kirchheiner J, Berghofer A, Bolk-Weischedel D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry 2000; 33: 78-80
32. Mendhekar DN, War L, Sharma JB, Jiloha RC. Olanzapine and pregnancy. Pharmacopsychiatry 2002; 35: 122-123
33. Friedman SH, Rosenthal MB. Treatment of perinatal delusional disorder: a case report. Int J Psychiatry Med 2003; 33: 391-394
34. Littrell KH, Johnson CG, Peabody CD, Hilligoss N. Antipsychotics during pregnancy. Am J Psychiatry 2000; 157: 1342
35. Neumann NU, Frasch K. Olanzapine and pregnancy. 2 case reports. Nervenarzt 2001; 72: 876-878
36. Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 2000; 20: 399-403